EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LINGO1-targeted antibody-drug conjugates improve efficacy and tolerability of antineoplastic therapies in Ewing sarcoma models

Zhichuan Zhu, Yusha Liu, Yu Deng, Zhijun Li, Albert S Baldwin, Pengda Liu

Journal of Clinical Investigation · 03.08.2026 · 136 (15)

DOI: 10.1172/jci204641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.08.2026. Verfasst von Zhichuan Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Bone Neoplasms, Immunoconjugates, Membrane Proteins. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North Carolina Biotechnology Center, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We reported LINGO1 as a potential marker on Ewing sarcoma cells that could enable targeted drug delivery, improving treatment effectiveness while reducing side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, EwingBone NeoplasmsImmunoconjugatesMembrane ProteinsNerve Tissue ProteinsNeoplasm ProteinsAntineoplastic AgentsHumansAnimalsMiceCell Line, Tumor

Stichwörter der Autor:innen

Bone diseaseCancerCell biologyOncologyTherapeutics

Substanzen

ImmunoconjugatesMembrane ProteinsNerve Tissue ProteinsNeoplasm ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Lineberger Comprehensive Cancer Center.
  • Department of Biochemistry and Biophysics.
  • Department of Biostatistics, and.
  • Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Förderung

  • North Carolina Biotechnology Center
  • U.S. Department of Defense

Zitieren

APA

Zhu, Z., Liu, Y., Deng, Y., Li, Z., Baldwin, A. S., & Liu, P. (2026). LINGO1-targeted antibody-drug conjugates improve efficacy and tolerability of antineoplastic therapies in Ewing sarcoma models. Journal of Clinical Investigation, 136(15). https://doi.org/10.1172/jci204641

Vancouver

Zhu Z, Liu Y, Deng Y, Li Z, Baldwin AS, Liu P. LINGO1-targeted antibody-drug conjugates improve efficacy and tolerability of antineoplastic therapies in Ewing sarcoma models. Journal of Clinical Investigation. 2026;136(15). doi:10.1172/jci204641

BibTeX
@article{Zhu2026,
  author = {Zhu, Zhichuan and Liu, Yusha and Deng, Yu and Li, Zhijun and Baldwin, Albert S and Liu, Pengda},
  title = {LINGO1-targeted antibody-drug conjugates improve efficacy and tolerability of antineoplastic therapies in Ewing sarcoma models},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {15},
  doi = {10.1172/jci204641}
}
Kostenlos starten →